AU2003300984A8 - Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative - Google Patents
Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivativeInfo
- Publication number
- AU2003300984A8 AU2003300984A8 AU2003300984A AU2003300984A AU2003300984A8 AU 2003300984 A8 AU2003300984 A8 AU 2003300984A8 AU 2003300984 A AU2003300984 A AU 2003300984A AU 2003300984 A AU2003300984 A AU 2003300984A AU 2003300984 A8 AU2003300984 A8 AU 2003300984A8
- Authority
- AU
- Australia
- Prior art keywords
- alendronate
- phosphonate
- vitamin
- bis
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 title 1
- 229940122361 Bisphosphonate Drugs 0.000 title 1
- 229940062527 alendronate Drugs 0.000 title 1
- 150000004663 bisphosphonates Chemical class 0.000 title 1
- 150000003710 vitamin D derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43368502P | 2002-12-16 | 2002-12-16 | |
US60/433,685 | 2002-12-16 | ||
US46020603P | 2003-04-02 | 2003-04-02 | |
US60/460,206 | 2003-04-02 | ||
PCT/US2003/040174 WO2004058235A2 (en) | 2002-12-16 | 2003-12-16 | Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003300984A8 true AU2003300984A8 (en) | 2004-07-22 |
AU2003300984A1 AU2003300984A1 (en) | 2004-07-22 |
Family
ID=32685268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003300984A Abandoned AU2003300984A1 (en) | 2002-12-16 | 2003-12-16 | Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative |
Country Status (7)
Country | Link |
---|---|
JP (3) | JP2006514695A (en) |
AU (1) | AU2003300984A1 (en) |
DE (1) | DE10393906T5 (en) |
GB (1) | GB2411116B (en) |
HK (1) | HK1078802A1 (en) |
IL (1) | IL169127A0 (en) |
WO (1) | WO2004058235A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8426391B2 (en) | 2006-02-03 | 2013-04-23 | Proventiv Therapeutics, Llc | Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 |
WO2007094779A1 (en) * | 2006-02-14 | 2007-08-23 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture |
SI2679228T1 (en) | 2006-06-21 | 2018-06-29 | Opko Ireland Global Holdings, Ltd. | Therapy using vitamin D repletion agent and vitamin D hormone replacement agent |
CA2671727C (en) * | 2006-12-20 | 2016-02-16 | Genpharm Ulc | A composition containing a bisphosphonic acid in combination with vitamin d |
WO2008074145A1 (en) * | 2006-12-20 | 2008-06-26 | Genpharm Ulc | Pharmaceutical composition comprising a hot-melt granulated lubricant |
ES2403107T3 (en) | 2007-04-25 | 2013-05-14 | Cytochroma Inc. | Vitamin D insufficiency and deficiency treatment method |
DK3342405T3 (en) | 2007-04-25 | 2019-11-11 | Opko Ireland Global Holdings Ltd | CONTROLLED RELEASE OF 25-HYDROXYVITAMINE D |
EP2148685A4 (en) | 2007-04-25 | 2010-07-28 | Cytochroma Inc | Methods and compounds for vitamin d therapy |
WO2008134523A1 (en) | 2007-04-25 | 2008-11-06 | Proventiv Therapeutics, Llc | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
KR101852042B1 (en) | 2008-04-02 | 2018-04-25 | 사이토크로마 인코포레이티드 | Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders |
EP3636280A1 (en) | 2010-03-29 | 2020-04-15 | Opko Ireland Global Holdings, Ltd. | Methods and compositions for reducing parathyroid levels |
KR101847947B1 (en) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | Stabilized modified release vitamin d formulation |
SG10201911274TA (en) | 2014-08-07 | 2020-02-27 | Opko Ireland Global Holdings Ltd | Adjunctive therapy with 25-hydroxyvitamin d |
SG10201913863TA (en) | 2016-03-28 | 2020-03-30 | Opko Ireland Global Holdings Limited | Methods of vitamin d treatment |
CN109364034B (en) * | 2018-11-26 | 2021-05-04 | 正大制药(青岛)有限公司 | Calcitriol preparation and preparation method thereof |
CN116211818B (en) * | 2023-03-10 | 2024-04-09 | 菲洋生物科技(吉林)有限公司 | Tablet containing alendronate sodium and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100317935B1 (en) * | 1999-10-20 | 2001-12-22 | 유승필 | Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
CA2454200A1 (en) * | 2001-07-17 | 2003-01-30 | Teva Pharmaceutical Industries Ltd. | Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
-
2003
- 2003-12-16 AU AU2003300984A patent/AU2003300984A1/en not_active Abandoned
- 2003-12-16 DE DE10393906T patent/DE10393906T5/en not_active Withdrawn
- 2003-12-16 JP JP2005509984A patent/JP2006514695A/en not_active Withdrawn
- 2003-12-16 WO PCT/US2003/040174 patent/WO2004058235A2/en active Application Filing
- 2003-12-16 GB GB0511750A patent/GB2411116B/en not_active Expired - Fee Related
-
2005
- 2005-06-09 IL IL169127A patent/IL169127A0/en not_active IP Right Cessation
-
2006
- 2006-02-06 HK HK06101577.3A patent/HK1078802A1/en not_active IP Right Cessation
-
2011
- 2011-08-02 JP JP2011169179A patent/JP2011241221A/en not_active Withdrawn
-
2014
- 2014-07-25 JP JP2014152061A patent/JP2014205711A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
HK1078802A1 (en) | 2006-03-24 |
JP2014205711A (en) | 2014-10-30 |
GB0511750D0 (en) | 2005-07-20 |
IL169127A0 (en) | 2009-02-11 |
DE10393906T5 (en) | 2006-01-12 |
GB2411116B (en) | 2009-04-29 |
WO2004058235A2 (en) | 2004-07-15 |
WO2004058235A3 (en) | 2005-02-24 |
AU2003300984A1 (en) | 2004-07-22 |
JP2006514695A (en) | 2006-05-11 |
GB2411116A (en) | 2005-08-24 |
JP2011241221A (en) | 2011-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL169127A0 (en) | Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative | |
AU2003280373A1 (en) | Method of administering bisphosphonates | |
EP1477119A4 (en) | Drug administration method | |
AU2003272590A1 (en) | Method for ophtalmic administration of medicament | |
ZA200508178B (en) | A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists | |
EP1507559A4 (en) | Delivery of microparticle-conjugated drugs for inhibition of stenosis | |
PL375558A1 (en) | A method of extending the dose range of vitamin d compounds | |
AU2002244881A1 (en) | Controlled release drug delivery system of pravastatin | |
PT1753393T (en) | Method for the innoformulation of a biocompatible galenic base | |
AU2003221699A1 (en) | Pharmaceutical preparation for taste masking | |
EP1683525A4 (en) | Sustained-release phenylalanine derivative preparation for oral administration | |
IL169352A0 (en) | Improved method for the production of vitamin b12 | |
AU2003270486A1 (en) | Tie-back connection for subsea well | |
IL165691A0 (en) | Epimerization of analogs of vitamin D | |
EP1498420A4 (en) | Phospholipid derivative | |
GB0220740D0 (en) | Administration of a system | |
EP1646640A4 (en) | Method for the preparation of highly pure 1-androstene derivatives | |
AP1925A (en) | Method for the prevention of malaria | |
AU2003269050A1 (en) | Method for decreasing bioavailability variability of an orally administered medicine | |
AU2003302116A1 (en) | Method of preparation of derivatives of substituted 2-aryl aikanoic acids | |
AU2003266714A8 (en) | Phospholipid derivative | |
AU2003244092A1 (en) | 1ss-METHYLCARBAPENEM DERIVATIVE FOR ORAL ADMINISTRATION | |
GB0328040D0 (en) | Pharmaceutical uses of bisphosphonates | |
AU2003226696A1 (en) | Improved method for the production of vitamin b12 | |
AU2003200836A1 (en) | Method for the preparation of matairesinol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |